Essex Woodlands IX, LLC 5
5 · EyePoint Pharmaceuticals, Inc. · Filed Feb 13, 2019
Insider Transaction Report
Form 5
Essex Woodlands Fund IX, L.P.
10% Owner
Transactions
- Conversion
Common Stock, $0.001 par value
2018-09-28$1.43/sh+16,211,822$23,182,905→ 41,903,956 total - Conversion
Common Stock, $0.001 par value
2018-09-28$1.43/sh+652,244$932,709→ 41,903,956 total(indirect: EW Healthcare Partners-A L.P.)
Footnotes (1)
- [F1]Includes 40,283,255 shares held by EW Healthcare Partners L.P. ("EWHP") and 1,620,701 shares held by EW Healthcare Partners-A L.P. ("EWHP-A"). Essex Woodlands Fund IX-GP, L.P. ("Fund IX-GP") is the general partner of EWHP and EWHP-A, respectively. Essex Woodlands IX, LLC (the "General Partner") is the general partner of Fund IX-GP. The General Partner holds sole voting and dispositive power over the shares held by EWHP and EWHP-A. The managers of the General Partner are Martin P. Sutter, R. Scott Barry, Ronald Eastman (also a member of the Issuer's board of directors) and Petri Vainio (collectively, the "Managers"), and may exercise voting and investment control over the shares only by the majority action of the Managers.